[{"NetIncomeLossConverted_3_Q3_USD":2107457000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":264031000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":264079000.0,"CommonStockSharesConverted_0_Q3_shares":260174000.0,"Assets_0_Q3_USD":11301633000.0,"RevenuesConverted_3_Q3_USD":4577863000.0,"RevenuesConverted_1_Q3_USD":1538271000.0,"EarningsPerShareBasic_1_Q3_USD":2.56,"StockholdersEquity_0_Q3_USD":8133473000.0,"EarningsPerShareDiluted_3_Q3_USD":7.98,"EarningsPerShareDiluted_1_Q3_USD":2.53,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":2761973000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":260313000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":260392000.0,"NetIncomeLossConverted_1_Q3_USD":667434000.0,"CommonStockSharesOutstanding_0_Q3_shares":260174000.0,"EarningsPerShareBasic_3_Q3_USD":8.1,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20201030"}]